INTRODUCTION.
Apoptosis has been suggested as a means to facilitate the resolution of pulmonary inflammation (1), however, uncontrolled apoptosis can also cause pulmonary disease and prolong inflammation (2) . The present study investigated the role of apoptosis and its relationship to necrosis during acute pulmonary inflammation caused by lipopolysaccharide (LPS).
METHODS.
Balb/c mice were administered with LPS intratracheally and bronchoalveolar lavage (BAL) was performed. Apoptosis was determined by measuring histone-bound DNA fragments using an ELISA kit (Boehringer Mannheim), while necrosis was assessed by measuring cell lysis using lactate dehydrogenase (LDH) assay.
RESULTS.
Treatment of mice with LPS causes a time-dependent increase in the number of inflammatory cells in the BAL fluids ( Fig. 1) . Control mice showed only resident alveolar macrophages with no apoptosis (Fig. 2A) . In contrast, LPS-treated mice showed clear apoptosis of BAL cells ( Fig. 2A) . Microscopic studies confirmed the presence of apoptotic neutrophils and macrophages ingesting apoptotic bodies (result not shown). The number of apoptotic neutrophils increased concomitantly with the increase in neutrophil influx that peaked 1 day after the treatment. However, no necrosis could be detected at this early time point whereas apoptosis continued to increase and peaked at day 2. Necrosis gradually increased by day 2 and reached a maximal level by day 3 where it subsequently declined. 
DISCUSSION.
In the present study, we demonstrated that the initial phase of lung inflammation, i.e., neutrophil influx, was not associated with necrosis but rather with apoptosis. However, necrosis developed subsequently to apoptosis, possibly due to inefficient phagocytic clearance of apoptotic cells. We conclude that the injurious effect of LPS is not a direct insult of this agent on the lung tissue but a consequence of inefficient apoptotic cell clearance that leads to the development of secondary necrosis and subsequent release of toxic contents.
